Implant Sciences Selected to Receive up to $2,000,000 from the Department of Homeland Security to Develop Next-Generation Explosives Trace Detection Systems
PR Newswire - Thu Oct 16, 11:12AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Department of Homeland Security has selected Implant Sciences' proposal to develop next generation explosives trace detection (ETD) screening systems for funding. The project, pending successful negotiations, is worth up to approximately $2 million to the Company.
Implant Sciences' QS-B220 Passes European Civil Aviation Conference Common Evaluation Process
PR Newswire - Mon Oct 06, 10:39AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the QS-B220 has successfully passed the European Civil Aviation Conference's (ECAC) Common Evaluation Process of Security Equipment (CEP) for airport checkpoint screening of passengers and baggage. The QS-B220 is the first Explosives Trace Detector (ETD) to pass ECAC's stringent laboratory testing protocol. The CEP was established to provide standards for security equipment performance across ECAC's 44 member nations. The QS-B220 was also recently added to the Transportation Security Administration's (TSA) Qualified Products List (QPL) in the U.S.
Implant Sciences Responds to Levi & Korsinsky, LLP Press Release/Solicitation
PR Newswire - Wed Oct 01, 7:00AM CDT
In response to a press release/general solicitation by the class action law firm, Levi & Korsinsky, LLP, Glenn D. Bolduc, CEO of Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, said today: "Levi & Korsinsky's press release/solicitation is identical to the press release it issued on August 8. The new release contains no new information and identifies no grounds whatsoever for an investigation of Implant Sciences or its board of directors. The firm has never contacted us directly, and we are not aware of any basis for an investigation. We do not believe this law firm's actions will benefit our shareholders, and we continue to encourage our shareholders and other interested parties to draw their own conclusions about the motivation behind this law firm's actions."
IMPLANT SCIENCES CORP. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Implant Sciences Corp.
Business Wire - Tue Sep 30, 3:02PM CDT
Levi & Korsinsky, LLP is investigating Implant Sciences Corp. (OTC:IMSC) in connection with possible claims of breaches of fiduciary duty.
Implant Sciences Reports Fourth Quarter and Fiscal 2014 Financial Results
PR Newswire - Mon Sep 29, 3:10PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three months and fiscal year ended June 30, 2014.
Implant Sciences to Announce Fourth Quarter and Fiscal 2014 Financial Results on September 29, 2014
PR Newswire - Thu Sep 25, 3:24PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Monday, September 29, 2014 at 4:15 p.m. to discuss the financial results for the quarter and fiscal year ended June 30, 2014.
Implant Sciences to Present at NIBA Conference in New York City on September 16, 2014
PR Newswire - Mon Sep 15, 9:35AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its CEO Glenn D. Bolduc is scheduled to present at the National Investment Banking Association's (NIBA) 132nd Investment Conference on Tuesday, September 16, 2014 at 11:55 am ET. The conference takes place in New York City on September 15th through 17th at the Roosevelt Hotel.
Implant Sciences Sells 12 QS-B220 Explosives Trace Detectors to South Korea's Largest Airport
PR Newswire - Tue Sep 09, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has sold 12 QS-B220 desktop explosives and drugs trace detectors to Incheon International Airport Corporation, operator of Incheon International Airport, the largest airport in South Korea. Implant Sciences' ETDs will be deployed for airport security and will replace existing systems the airport had in place from a competitor.
Implant Sciences to Present at Rodman & Renshaw Conference in New York City on September 10, 2014
PR Newswire - Mon Sep 08, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its CEO Glenn D. Bolduc is scheduled to present at the Rodman & Renshaw 16th Annual Global Investment Conference on Wednesday, September 10, 2014 at 9:10 am. The conference takes place in New York City on September 8th through 10th at the New York Palace Hotel.
Implant Sciences Sells 43 QS-H150 Explosives Trace Detection Systems in China
PR Newswire - Thu Sep 04, 9:49AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has sold 43 of its QS-H150 Explosives Trace Detection systems to customers in China. Organizations purchasing the systems include a police department and a mass transit authority.
OTC Daily News Report
PR Newswire Europe - Wed Sep 03, 8:05AM CDT
LONDON, September 3, 2014 /PRNewswire/ --
Implant Sciences Wins $1.2 Million Contract for Trace Detectors to EU Country
PR Newswire - Tue Sep 02, 10:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has sold $1.2 million worth of trace detectors to a customer in the European Union. The units will be deployed for critical infrastructure protection and homeland security.
Implant Sciences QS-B220 explosives trace detector approved for passenger and baggage screening at U.S. airports
PR Newswire - Thu Aug 28, 1:32PM CDT
Marking a major milestone for the Company, Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its QS-B220 desktop explosives trace detector has successfully completed the certification process for the United States Transportation Security Administration's (TSA) Explosive Trace Detection (ETD) qualification requirements for aviation checkpoint and checked baggage screening. The QS-B220 becomes the first ETD with a non-radioactive source to be added to the TSA's Qualified Product List (QPL).
Implant Sciences CEO Invited to Attend Inaugural U.S.-Africa Business Forum by U.S. Department of Commerce
PR Newswire - Tue Aug 05, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its CEO Glenn D. Bolduc has been invited to attend the U.S.-Africa Business Forum on Tuesday, August 5, 2014 in Washington D.C. Mr. Bolduc is one of a select group of U.S. CEOs invited to the event co-hosted by the U.S. Department of Commerce and Bloomberg Philanthropies. Heads of state will engage with business executives from both sides of the Atlantic in conversations about successes and solutions to build greater access for trade and investment in Africa. President Obama will participate in the conversation with CEOs and government leaders from the U.S. and Africa.
Implant Sciences Ships $550,000 in Explosives Trace Detectors to Domestic and International Customers
PR Newswire - Thu Jul 17, 6:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today stated that it has shipped over $550,000 in previously unannounced orders of QS-H150 and QS-B220s to multiple customers in North America, Europe, Middle East, and Africa. Customers for the handheld and desktop explosives trace detectors include a major international logistics corporation, a construction company, an airport, and the embassy of a foreign nation. The systems will be used for building security and for the screening of air cargo, and airline passengers and baggage.
Implant Sciences Ranked One of the Fastest Growing Public Companies in Massachusetts
PR Newswire - Wed Jul 02, 9:54AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the Boston Business Journal has included Implant Sciences in its annual list of the 50 fastest growing publicly traded companies in Massachusetts. Ranked by two-year revenue growth as of each company's most recent fiscal year, Implant Sciences was 23rd in the state, with an 80.65% increase in revenues for the two-year period from July 1, 2011 to June 30, 2013. For the one-year period between July 1, 2012 and June 30, 2013, Implant Sciences had a revenue increase of 252.82%.
American Association of Airport Executives' CEO Todd Hauptli Visits Implant Sciences
PR Newswire - Tue Jul 01, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that Todd Hauptli, President and Chief Executive Officer of the American Association of Airport Executives (AAAE) visited and toured the Company's headquarters and manufacturing facility.